Evaluation of enhanced external counterpulsation therapy for nonarteritic anterior ischemic optic neuropathy

BMC Ophthalmology

Wenhui Zhu¹  Hui Yang²  Lixia Lin²  Nan Ma²  Xiaofeng Lin² 

[1] Department of Ophthalmology, The First Affiliated Hospital of Sun Yat-sen University;Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University;

关键词: Nonarteritic anterior ischemic optic neuropathy;    Enhanced external counterpulsation;    Visual acuity;    Visual field;   

DOI  :  10.1186/s12886-020-01509-7

来源: DOAJ

【 摘 要 】

Abstract Background To explore the effects of enhanced external counterpulsation (EECP) and its underlying influencing factors in nonarteritic anterior ischemic optic neuropathy (NAION) patients. Methods Patients at Zhongshan Ophthalmic Center with recent-onset (< 8 weeks) NAION were retrospectively recruited. The patients had decided whether or not they would undergo EECP treatment, and the patients who declined were included in the control group. The effectiveness of EECP was evaluated by comparing the visual function and fellow eye involvement in patients with and without EECP treatment. Results In total, 61 patients (76 eyes) were included. Twenty-nine patients (37 eyes) underwent EECP treatment, while 32 patients (39 eyes) were included in the control group. Mean time from NAION onset to EECP initiation was 27.59 ± 16.70 days. In the EECP group, the mean EECP duration was 31.57 ± 18.45 days. EECP was well tolerated by all patients. However, there was no significant difference in visual function between the EECP and control groups. Furthermore, there was no evidence of the effectiveness of EECP in the subgroup analysis of patients with different systemic health conditions. Among the 42 patients with monocular NAION, the sequential attack rate was comparable between the EECP (27.78%) and control (25.00%) groups. Conclusion This study is the first nonrandomized controlled study to evaluate the effectiveness of EECP in NAION patients. Unfortunately, we failed to demonstrate the effectiveness of EECP in NAION at the 6-month follow-up. Any further application of EECP in NAION patients should be cautious.

【 授权许可】

Unknown